Enhancement of Silymarin Anti-Fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) Β-Cyclodextrins in a Mouse Model of Liver Fibrosis

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00883

Related search